IDO Plus PD-1 Inhibitor Combo Sparks Responses in Bladder and Cervical Cancers OncLive, 12 Nov 2017 Jason J. Luke, MD, FACP The combination of nivolumab (Opdivo), a PD-1 inhibitor, and BMS-986205, a novel IDO inhibitor…